🟢 MDxHealth is trading 6.83% up in pre-market — catalyst unclear

MDxHealth is trading at $0.64, up 6.83%, with the catalyst unclear.

• No company-specific announcement was identified for September 23, 2026; the official 2026 archive shows no releases dated September 22 or 23.
• The latest major update remains its August 13, 2026, second-quarter results: revenue grew 16% to $27.2 million, with no stated connection to the move.
• Broader markets are only modestly higher; the move may reflect limited pre-market liquidity.